好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Pick’s Disease: Clinicopathologic Characterization of 21 Cases
Aging, Dementia, and Behavioral Neurology
S33 - Aging and Dementia: Non-Alzheimer Dementia (5:18 PM-5:30 PM)
010

To describe the clinical features, neuropsychological profiles and coexistent pathologies in 21 cases of pathologically confirmed Pick’s disease. 

Pick’s disease is a unique pathologic subtype of frontotemporal lobar degeneration associated with 3 repeat (3R) tau aggregates. Very few studies have examined the clinical variability and disease progression in Pick’s disease due to its rarity.

This study was a retrospective analysis of patients with pathologically confirmed Pick’s disease evaluated at Mayo Clinic Rochester or Jacksonville. Cases were seen between 1995 and 2018 and identified through an existing database.

Twenty-one cases with sufficient clinical data were identified. Behavioral variant FTD (bvFTD) (12/21) was the most common phenotype followed by primary progressive aphasia (PPA) (7/21), corticobasal syndrome (CBS) (1/21) and amnestic dementia (1/21).  Mean age at disease onset was 58 (SD 8.4) years, with PPA cases (µ=51 SD 5.3) presenting earlier than bvFTD (µ=58, SD 5.6). Mean disease duration overall was 11.2 years (SD 3.9) and did not differ significantly between bvFTD (µ=11, SD 2.9) and PPA (µ=11.6, SD 4.5). Age at death was not significantly different in PPA (µ=64, SD 5.2) compared to bvFTD (µ=69, SD 6.5). Half of the cases (n=11/21) demonstrated pure Pick’s disease pathology while some showed co-existent Alzheimer’s disease (n=6), cerebral amyloid angiopathy (n=2), Lewy body disease (n=1) and primary age-related tauopathy (n=1).

In accordance with the literature, our study showed bvFTD and PPA are the most common clinical phenotypes associated with Pick’s pathology, although rare presentations such as CBS were also seen. There was no difference in disease duration between bvFTD and PPA cases. Coexisting non-Pick’s disease pathology was also present in many cases. Our study highlights the clinical and pathologic heterogeneity in Pick’s disease.

Authors/Disclosures
Parichita Choudhury, MD (Banner Sun Health Research Institute)
PRESENTER
The institution of Dr. Choudhury has received research support from Lewy Body Dementia Association. The institution of Dr. Choudhury has received research support from Arizona Alzheimer's Consortium.
Eugene L. Scharf, MD (Mayo Clinic) The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities.
No disclosure on file
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
David T. Jones, MD (Mayo Clinic) Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Julie A. Fields, PhD (Mayo Clinic) The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Melissa Murray, PhD (Mayo Clinic) Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative.
Neill R. Graff-Radford, MD, FAAN (Mayo Clinic Jacksonville) The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Dennis W. Dickson, MD (Mayo Clinic) Dr. Dickson has nothing to disclose.
Ronald C. Petersen, MD, PhD, FAAN (Mayo Clinic) Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
David S. Knopman, MD, FAAN (Mayo Clinic) Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Mary M. Machulda, PhD (Mayo Clinic) The institution of Dr. Machulda has received research support from NIH.
No disclosure on file
No disclosure on file
Keith A. Josephs, Jr., MD, FAAN (Mayo Clinic) Dr. Josephs has nothing to disclose.
Ross Reichard Ross Reichard has nothing to disclose.
Joseph E. Parisi, MD (Mayo Clinic) Dr. Parisi has nothing to disclose.
Bradley F. Boeve, MD, FAAN (Mayo Clinic) Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.